Disruption of circadian rhythm by alternating light-dark cycles aggravates atherosclerosis development in APOE*3-Leiden.CETP mice.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Schilperoort, Maaikevan den Berg, Rosa
Bosmans, Laura A
van Os, Bram W
Dollé, Martijn E T
Smits, Noortje A M
Guichelaar, Teun
van Baarle, Debbie
Koemans, Lotte
Berbée, Jimmy F P
Deboer, Tom
Meijer, Johanna H
de Vries, Margreet R
Vreeken, Dianne
van Gils, Janine M
Willems van Dijk, Ko
van Kerkhof, Linda W M
Lutgens, Esther
Biermasz, Nienke R
Rensen, Patrick C N
Kooijman, Sander
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Disruption of circadian rhythm by alternating light-dark cycles aggravates atherosclerosis development in APOE*3-Leiden.CETP mice.Published in
J Pineal Res 2019;e12614 advance online publication (ahead of print)PMID
31599473ae974a485f413a2113503eed53cd6c53
10.1111/jpi.12614
Scopus Count
Collections
Related articles
- Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP mice.
- Authors: Auvinen HE, Wang Y, Princen H, Romijn JA, Havekes LM, Smit JW, Meijer OC, Biermasz NR, Rensen PC, Pereira AM
- Issue date: 2013
- Continuous Light Does Not Affect Atherosclerosis in APOE*3-Leiden.CETP Mice.
- Authors: Schilperoort M, van den Berg R, Coomans CP, Khedoe PPSJ, Ramkisoensing A, Boekestijn S, Wang Y, Berbée JFP, Meijer JH, Biermasz NR, Rensen PCN, Kooijman S
- Issue date: 2020 Dec
- Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration.
- Authors: Wang Y, Parlevliet ET, Geerling JJ, van der Tuin SJ, Zhang H, Bieghs V, Jawad AH, Shiri-Sverdlov R, Bot I, de Jager SC, Havekes LM, Romijn JA, Willems van Dijk K, Rensen PC
- Issue date: 2014 Feb
- Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
- Authors: Westerterp M, van der Hoogt CC, de Haan W, Offerman EH, Dallinga-Thie GM, Jukema JW, Havekes LM, Rensen PC
- Issue date: 2006 Nov
- Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
- Authors: Hurt-Camejo E, Gautier T, Rosengren B, Dikkers A, Behrendt M, Grass DS, Rader DJ, Tietge UJ
- Issue date: 2013 Dec